Company Overview and News

 
Airline Industry Outlook - April 2018

8h zacks
Airline stocks are unlikely to grab major headlines in the first-quarter 2018 reporting cycle, which will see reports from many sector participants in the coming days. High fuel costs are likely to limit bottom-line growth in the reporting cycle. Moreover, multiple flight cancellations due to foul weather is also likely to weigh on results.
Upvote Downvote

 
Will Boeing Co Be Grounded Over Trade War Worries?

9h investorplace
Boeing Co (NYSE:BA) was looking more like a rocket ship rather than a plane gradually gaining altitude. But those robust gains — up 90% in 2017 — have been shot down. Boeing stock has tumbled from a high of $371 in February to about $311 at its recent low.
Upvote Downvote

 
CORRECTED-Southwest challenged engine maker CFM over proposed FAA inspections

10h reuters
April 19 (Reuters) - Southwest Airlines Co clashed with engine maker CFM over the timing of proposed inspections and with regulators over costs after a 2016 accident involving the airline that was caused by a fan blade separating, public documents showed.
Upvote Downvote

 
Stock Market News For Apr 19, 2018

15h zacks
U.S. stocks closed mixed on Wednesday after gaining over two consecutive winning sessions. However, movements of indexes were modest in either direction. The Dow’s decline was driven by a plunge in the share price of IBM. However, the S&P 500 and Nasdaq finished in the green. Meanwhile, energy stocks gained after a 2.9% surge in oil prices and transportation sector starts off a strong earnings session.
Upvote Downvote

 
United Continental Holdings Inc Stock Readies for Takeoff

16h investorplace
United Continental Holdings Inc (NYSE:UAL), the airline best known for dogs dying in its cargo holds, announced its Q1 2018 earnings yesterday after the close of trading. United stock has a history of big moves after earnings announcements, both good and bad, so it’s not surprising that the good news it delivered Wednesday pushed UAL higher by more than 6%
Upvote Downvote

 
3 Airline Stocks to Buy Post UAL, DAL's Strong Q1 Reports

17h zacks
The Q1 earnings season for the airline space has taken off on a positive note. Two airline majors — United Continental Holdings, Inc. (UAL - Free Report) and Delta Air Lines, Inc. (DAL - Free Report) — that have reported thus far have outperformed with respect to revenues as well as earnings per share.
Upvote Downvote

 
The Zacks Analyst Blog Highlights: Delta Air Lines, United Continental Holdings, Allegiant Travel, Southwest Airlines and JetBlue Airways

17h zacks
Chicago, IL – April 19, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Delta Air Lines (DAL - Free Report) , United Continental Holdings (UAL - Free Report) , Allegiant Travel Company (ALGT - Free Report) , Southwest Airlines Co.
Upvote Downvote

 
Transportation Sector Starts Q1 on Strong Note: Key Takeaways

17h zacks
The diversified transportation sector, which includes airline companies, railroads, truckers and shippers, among others, got off to an impressive start in first-quarter 2018 earnings season. As the U.S. economy continues to grow, demand for carriage is also increasing and this momentum is anticipated to sustain in 2018. Transportation sector is the lifeblood of the economy as it moves freights across the country and offshore.
Upvote Downvote

 
Airline Stock Roundup: Earnings Beat at DAL & UAL, ALGT's Safety Issues & More

18h zacks
Last week, Delta Air Lines (DAL - Free Report) kick-started the first-quarter earnings season for the airline space. This Atlanta, GA-based carrier reported better-than-expected revenues and earnings per share. However, high fuel costs contributed to a year-over-year decline in earnings.
Upvote Downvote

 
Southwest challenged engine maker CFM over proposed FAA inspections

2018-04-19 reuters
(Reuters) - Southwest Airlines Co clashed with engine maker CFM over the timing of proposed inspections and with regulators over costs after a 2016 accident involving the airline that was caused by a fan blade separating, public documents showed.
Upvote Downvote

 
United Continental Holdings' (UAL) CEO Oscar Munoz on Q1 2018 Results - Earnings Call Transcript

2018-04-18 seekingalpha
United Continental Holdings, Inc. (NYSE:UAL) Q1 2018 Results Earnings Conference Call April 18, 2018 10:30 AM ET
Upvote Downvote

 
UAL / United Continental Holdings, Inc. 10-Q (Quarterly Report)

2018-04-18 sec.gov
10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
Upvote Downvote

 
UAL / United Continental Holdings, Inc. 10-Q (Quarterly Report)

2018-04-18 sec.gov
10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
Upvote Downvote

 
United Continental Holdings, Inc 2018 Q1 - Results - Earnings Call Slides

2018-04-18 seekingalpha
The following slide deck was published by United Continental Holdings, Inc in conjunction with their 2018 Q1 earnings call.
Upvote Downvote

 
Stock Market News For Apr 18, 2018

2018-04-18 zacks
U.S. stock markets continued their winning streak for the second consecutive day supported by robust first-quarter earnings results and strong economic data. All three major indexes closed at highest level in about a month. Moreover, all three indexes closed above their 50-day moving average, an important metric to calculate short-term price momentum of securities.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 910047109